<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: <z:e sem="disease" ids="C0085390" disease_type="Neoplastic Process" abbrv="LFS">Li-Fraumeni syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>), characterized by predisposition to early <z:hpo ids='HP_0003674'>onset</z:hpo> of a variety of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, is usually associated with germline mutation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor gene, TP53 </plain></SENT>
<SENT sid="1" pm="."><plain>Mutation carriers are at increased risk of multiple <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e>, many of which arise in previous radiation-therapy sites </plain></SENT>
<SENT sid="2" pm="."><plain>In patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>, <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> is uncommon and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is rare </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: To evaluate the morphologic, cytogenetic, and molecular diagnostic findings of 3 unique cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> arising in patients with germline TP53 mutation, 2 with classic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>DESIGN: We searched the <z:e sem="disease" ids="C0085390" disease_type="Neoplastic Process" abbrv="LFS">Li-Fraumeni Syndrome</z:e> Registry in the Department of Genetics at the University of Texas M </plain></SENT>
<SENT sid="5" pm="."><plain>D </plain></SENT>
<SENT sid="6" pm="."><plain>Anderson <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center (Houston, Texas) and identified 3 patients with documented germline TP53 mutations or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> who had developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> during a period of 6 years (2000-2005) </plain></SENT>
<SENT sid="7" pm="."><plain>The clinical, cytogenetic, and molecular diagnostic data and bone marrow aspirate smears and biopsies on <z:hpo ids='HP_0000001'>all</z:hpo> patients were reviewed </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemical staining with antibody to p53 was also performed </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Two patients met the criteria for classic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>; one had no history of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in first-degree relatives </plain></SENT>
<SENT sid="10" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> followed chemotherapy and radiation therapy and progressed to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> in 2 patients </plain></SENT>
<SENT sid="11" pm="."><plain>Cytogenetic analysis demonstrated chromosome 5 abnormalities in a complex karyotype in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="12" pm="."><plain>Two patients died, one of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and one with <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> multiforme, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and persistent <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> may develop <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, which is most likely therapy-related and is associated with cytogenetic markers of poor prognosis </plain></SENT>
</text></document>